Results 201 to 210 of about 15,815 (221)

Antidepressants as modulators of P2X7 receptor activity

Neuroscience
According to the Pan American Health Organization, more than 300 million people suffer from depression worldwide. Despite the alarming numbers, current drug treatments produce partial results, as they focus on only one pillar of depression: neurotransmitters.
Vitor Nascimento Vidal, Guilherme Pegas Teixeira, Juliana Vieira Faria, Jonathas Albertino de Souza Oliveira, Murilo Lamim Bello, Leandro Rocha, Robson Xavier Faria   +6 more
openaire   +2 more sources

P2X7 Receptor and Apoptosis

Critical Care Medicine, 2014
Jianru, Li, Jingyin, Chen, Gao, Chen
openaire   +2 more sources

The P2X7 receptor as a new pharmacological target for retinal diseases

Biochemical Pharmacology, 2022
Chiara Bianca Maria Platania, Claudio Bucolo   +1 more
exaly  

The P2X7 Receptor

2022
openaire   +1 more source

Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications

Medicinal Research Reviews, 2023
Yaling Yin, Linyu Wei, Emily A Caseley
exaly  

ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer

European Journal of Medicinal Chemistry, 2023
Cheng Zuo, Sai-Yang Zhang
exaly  

Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states

British Journal of Pharmacology, 2007
Michael F Jarvis
exaly  

Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding

British Journal of Pharmacology, 2007
I P Chessell
exaly  

P2X7 receptors and bone

Bone, 2012
openaire   +1 more source

The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases

Clinica Chimica Acta, 2018
Lu He, Lanfang Li, Linxi Chen
exaly